Difficulty Swallowing Medications Tied to Motor Problems in Study
Difficulty in swallowing medications, either tablets or capsules, was common among people with Parkinson’s disease, a study reports. This…
Articles by Steve Bryson, PhD
Protein Clumps Marking Parkinson’s May Start in Digestive Tract
Toxic clumps of the alpha-synuclein protein, the underlying cause of neurodegeneration in Parkinson’s disease, may originate in the digestive…
Swallowing Difficulties Linked to Autonomic Nerve Dysfunction
Swallowing difficulties in people with Parkinson’s disease are associated with the dysfunction of nerves that supply the heart muscle…
Smallest Clumps of Alpha-synuclein Protein Seen to Drive Parkinson’s
Alpha-synuclein protein clumps — the toxic aggregates related to nerve damage in Parkinson’s disease — vary, including in size,…
50 Parkinson’s Genes Found With New Multidisciplinary Approach
Fifty new genes that modified signs of Parkinson’s disease in a fruit fly model have been discovered using a…
Trial to Detect Alpha-Synuclein Deposits in Patients’ Eyes Underway
A Phase 1/2a clinical trial testing the ability of AMDX-2011P to safely detect abnormal protein deposits in the retina of…
How Parkinson’s Disease Spreads in the Brain Shown in Mouse Study
Clumps of alpha-synuclein protein, which build to toxic levels in the brain and spinal cord of Parkinson’s disease patients,…
Oral GT-02287 Improves Fine Motor Skills in Mice
Gain Therapeutics’ GT-02287, an oral candidate therapy for Parkinson’s disease, led to dose-dependent improvements in the health of…
Way of Visualizing Alpha-Synuclein Clumps in Living Brain Reported
Using a newly created probe and non-invasive PET scans, researchers were able to visualize sites of alpha-synuclein protein clumps —…
Machine Learning IDs Approved Meds With Potential for Parkinson’s
Screening a large database with machine learning tools helped scientists identify approved medicines for other diseases that reduced the risk…